METASTATIC SQUAMOUS CELL CARCINOMA
Clinical trials for METASTATIC SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can targeted radiation boost Immunotherapy's power against head and neck cancer?
Disease control CompletedThis trial is testing whether adding targeted radiation (SBRT) to two immunotherapy drugs, durvalumab and tremelimumab, can better control metastatic head and neck cancer. The study includes adults with this cancer that has spread, and the radiation is given between cycles of the…
Matched conditions: METASTATIC SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Experimental combo targets Hard-to-Treat head and neck cancers
Disease control CompletedThis early-phase trial tested a combination of two drugs — IRX-2 and durvalumab — in 19 people with advanced head and neck cancer that could not be cured by standard treatments. The goal was to see if the combination was safe and could boost the immune response inside tumors. The…
Matched conditions: METASTATIC SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC